C& Co., Ltd. (CEO Park Sang-yong), a medical tourism and bio MICE specialized company, announced on the 16th that it had concluded the '2025 Mongolia Overseas Hospital Linkage Corporate Consultation' held in Ulaanbaatar, Mongolia in early July.
This consultation meeting was organized by the Gimhae Biomedical Industry Promotion Association and was held with the purpose of supporting the expansion of domestic medical institutions overseas and attracting Mongolian patients. Many people, including major Mongolian health and medical institutions, local hospital officials, and medical tourism-related companies, attended the event.
C&T was in charge of planning and operating this event, supporting demand discovery and buyer matching between domestic bio and medical industry companies and relevant organizations and companies in Mongolia. Promising domestic companies in various fields such as medical devices, biomaterials, and functional cosmetics participated in the consultation session, and the companies explored specific possibilities for cooperation through 1:1 customized consultations.
In particular, medical device company Opirex (CEO Ji-hyeok Yoon) and biomaterials company Bel Abel Bio (CEO Seon-hee Lee) signed strategic business agreements (MOUs) with MG Hospital (Mungun Guur Hospital), a private hospital in Mongolia. Opirex plans to expand medical device exports, and Bel Abel Bio plans to begin full-scale joint research cooperation based on natural materials.
CEO Park Sang-yong of C&C said, “This consultation session served as an opportunity to lay the foundation for enhancing the global competitiveness of domestic medical institutions and attracting Mongolian patients,” and added, “We will continue to work to expand the overseas expansion of K-medical care and the medical tourism network in various countries, including Mongolia.”
- See more related articles
You must be logged in to post a comment.